Skip to main content
. 2017 Feb 27;6(3):e005394. doi: 10.1161/JAHA.116.005394

Figure 3.

Figure 3

Effect of mycophenolate mofetil (MMF) on circulating B and T cells in vehicle or MMF‐treated control mice. Cells were stained with anti‐mouse CD45R phycoerythrin–cyanine 7 (A) or with anti‐mouse CD3 phycoerythrin–cyanine 7, anti‐mouse CD4 phycoerythrin, and anti‐mouse CD8 allophycocyanin (B and C). A, Percentage of CD45R+ B cells at 27 weeks (0 weeks of MMF), 31 weeks (4 weeks of MMF), and 35 weeks (8 weeks of MMF). B, Percentage of CD3+CD4+ T cells at 27 weeks (0 weeks of MMF), 31 weeks (4 weeks of MMF), and 35 weeks (8 weeks of MMF). C, Percentage of CD3+CD8+ T cells at 27 weeks (0 weeks of MMF), 31 weeks (4 weeks of MMF), and 35 weeks (8 weeks of MMF). No significant differences were seen in relative percentages of T cells at any time points.